Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine with Busulfan and Fludarabine for AML/MDS Transplant
NCT01471444Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2011
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of clofarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2011; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01471444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471444.